Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $105.46B | $99.85B | $105.10B | $102.24B | $98.43B | $94.07B | $96.96B | $94.88B |
| Cost of revenue | $90.35B | $84.80B | $92.13B | $89.07B | $85.32B | $80.19B | $84.81B | $82.87B |
| Gross profit | $15.11B | $15.05B | $12.97B | $13.17B | $13.11B | $13.88B | $12.14B | $12.01B |
| Gross margin | 14.3% | 15.1% | 12.3% | 12.9% | 13.3% | 14.8% | 12.5% | 12.7% |
| Operating expenses | $11.05B | $10.94B | $11.46B | $17.01B | $11.21B | $11.02B | $10.53B | $11.73B |
| Operating income | $4.06B | $4.11B | $1.52B | −$3.84B | $1.89B | $2.85B | $1.61B | $282.00M |
| Operating margin | 3.9% | 4.1% | 1.4% | -3.8% | 1.9% | 3.0% | 1.7% | 0.3% |
| EBITDA | $5.19B | $5.22B | $2.67B | $3.02B | $3.07B | $4.01B | $2.77B | $2.61B |
| Interest income | $641.00M | $574.00M | $594.00M | $632.00M | $487.00M | $520.00M | $755.00M | $550.00M |
| Interest expense | −$757.00M | −$774.00M | −$787.00M | −$784.00M | −$763.00M | −$785.00M | −$758.00M | −$752.00M |
| Income before taxes | $3.98B | $3.94B | $1.35B | −$3.48B | $1.65B | $2.62B | $2.13B | $105.00M |
| Income taxes | $982.00M | $981.00M | −$1.57B | $508.00M | $634.00M | $835.00M | $503.00M | $34.00M |
| Net income | $3.00B | $2.96B | $2.92B | −$3.99B | $1.01B | $1.78B | $1.62B | $71.00M |
| Net margin | 2.8% | 3.0% | 2.8% | -3.9% | 1.0% | 1.9% | 1.7% | 0.1% |
| EPS, basic | $2.33 | $2.31 | $2.31 | −$3.13 | $0.81 | $1.41 | $1.30 | $0.07 |
| EPS, diluted | $2.31 | $2.30 | $2.30 | −$3.13 | $0.80 | $1.41 | $1.30 | $0.07 |
| Diluted shares | 1.29B | 1.28B | 1.28B | 1.27B | 1.27B | 1.26B | 1.26B | 1.26B |
Figures describe CVS Health shares, not any token. As of Aug 5, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.